Hepatic steatosis relates to gastrointestinal microbiota changes in obese girls with polycystic ovary syndrome.

<h4>Objective</h4>Hepatic steatosis (HS) is common in adolescents with obesity and polycystic ovary syndrome (PCOS). Gut microbiota are altered in adults with obesity, HS, and PCOS, which may worsen metabolic outcomes, but similar data is lacking in youth.<h4>Methods</h4>Thir...

Full description

Bibliographic Details
Main Authors: Beza Jobira, Daniel N Frank, Lori J Silveira, Laura Pyle, Megan M Kelsey, Yesenia Garcia-Reyes, Charles E Robertson, Diana Ir, Kristen J Nadeau, Melanie Cree-Green
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0245219
_version_ 1818574597553913856
author Beza Jobira
Daniel N Frank
Lori J Silveira
Laura Pyle
Megan M Kelsey
Yesenia Garcia-Reyes
Charles E Robertson
Diana Ir
Kristen J Nadeau
Melanie Cree-Green
author_facet Beza Jobira
Daniel N Frank
Lori J Silveira
Laura Pyle
Megan M Kelsey
Yesenia Garcia-Reyes
Charles E Robertson
Diana Ir
Kristen J Nadeau
Melanie Cree-Green
author_sort Beza Jobira
collection DOAJ
description <h4>Objective</h4>Hepatic steatosis (HS) is common in adolescents with obesity and polycystic ovary syndrome (PCOS). Gut microbiota are altered in adults with obesity, HS, and PCOS, which may worsen metabolic outcomes, but similar data is lacking in youth.<h4>Methods</h4>Thirty-four adolescents with PCOS and obesity underwent stool and fasting blood collection, oral glucose tolerance testing, and MRI for hepatic fat fraction (HFF). Fecal bacteria were profiled by high-throughput 16S rRNA gene sequencing.<h4>Results</h4>50% had HS (N = 17, age 16.2±1.5 years, BMI 38±7 kg/m2, HFF 9.8[6.5, 20.7]%) and 50% did not (N = 17, age 15.8±2.2 years, BMI 35±4 kg/m2, HFF 3.8[2.6, 4.4]%). The groups showed no difference in bacterial α-diversity (richness p = 0.202; evenness p = 0.087; and diversity p = 0.069) or global difference in microbiota (β-diversity). Those with HS had lower % relative abundance (%RA) of Bacteroidetes (p = 0.013), Bacteroidaceae (p = 0.009), Porphyromonadaceae (p = 0.011), and Ruminococcaceae (p = 0.008), and higher Firmicutes:Bacteroidetes (F:B) ratio (47.8% vs. 4.3%, p = 0.018) and Streptococcaceae (p = 0.034). Bacterial taxa including phyla F:B ratio, Bacteroidetes, and family Bacteroidaceae, Ruminococcaceae and Porphyromonadaceae correlated with metabolic markers.<h4>Conclusions</h4>Obese adolescents with PCOS and HS have differences in composition of gut microbiota, which correlate with metabolic markers, suggesting a modifying role of gut microbiota in HS and PCOS.
first_indexed 2024-12-15T00:28:40Z
format Article
id doaj.art-852b5415550740c6967d716a8e09f6e4
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-15T00:28:40Z
publishDate 2021-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-852b5415550740c6967d716a8e09f6e42022-12-21T22:42:04ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01161e024521910.1371/journal.pone.0245219Hepatic steatosis relates to gastrointestinal microbiota changes in obese girls with polycystic ovary syndrome.Beza JobiraDaniel N FrankLori J SilveiraLaura PyleMegan M KelseyYesenia Garcia-ReyesCharles E RobertsonDiana IrKristen J NadeauMelanie Cree-Green<h4>Objective</h4>Hepatic steatosis (HS) is common in adolescents with obesity and polycystic ovary syndrome (PCOS). Gut microbiota are altered in adults with obesity, HS, and PCOS, which may worsen metabolic outcomes, but similar data is lacking in youth.<h4>Methods</h4>Thirty-four adolescents with PCOS and obesity underwent stool and fasting blood collection, oral glucose tolerance testing, and MRI for hepatic fat fraction (HFF). Fecal bacteria were profiled by high-throughput 16S rRNA gene sequencing.<h4>Results</h4>50% had HS (N = 17, age 16.2±1.5 years, BMI 38±7 kg/m2, HFF 9.8[6.5, 20.7]%) and 50% did not (N = 17, age 15.8±2.2 years, BMI 35±4 kg/m2, HFF 3.8[2.6, 4.4]%). The groups showed no difference in bacterial α-diversity (richness p = 0.202; evenness p = 0.087; and diversity p = 0.069) or global difference in microbiota (β-diversity). Those with HS had lower % relative abundance (%RA) of Bacteroidetes (p = 0.013), Bacteroidaceae (p = 0.009), Porphyromonadaceae (p = 0.011), and Ruminococcaceae (p = 0.008), and higher Firmicutes:Bacteroidetes (F:B) ratio (47.8% vs. 4.3%, p = 0.018) and Streptococcaceae (p = 0.034). Bacterial taxa including phyla F:B ratio, Bacteroidetes, and family Bacteroidaceae, Ruminococcaceae and Porphyromonadaceae correlated with metabolic markers.<h4>Conclusions</h4>Obese adolescents with PCOS and HS have differences in composition of gut microbiota, which correlate with metabolic markers, suggesting a modifying role of gut microbiota in HS and PCOS.https://doi.org/10.1371/journal.pone.0245219
spellingShingle Beza Jobira
Daniel N Frank
Lori J Silveira
Laura Pyle
Megan M Kelsey
Yesenia Garcia-Reyes
Charles E Robertson
Diana Ir
Kristen J Nadeau
Melanie Cree-Green
Hepatic steatosis relates to gastrointestinal microbiota changes in obese girls with polycystic ovary syndrome.
PLoS ONE
title Hepatic steatosis relates to gastrointestinal microbiota changes in obese girls with polycystic ovary syndrome.
title_full Hepatic steatosis relates to gastrointestinal microbiota changes in obese girls with polycystic ovary syndrome.
title_fullStr Hepatic steatosis relates to gastrointestinal microbiota changes in obese girls with polycystic ovary syndrome.
title_full_unstemmed Hepatic steatosis relates to gastrointestinal microbiota changes in obese girls with polycystic ovary syndrome.
title_short Hepatic steatosis relates to gastrointestinal microbiota changes in obese girls with polycystic ovary syndrome.
title_sort hepatic steatosis relates to gastrointestinal microbiota changes in obese girls with polycystic ovary syndrome
url https://doi.org/10.1371/journal.pone.0245219
work_keys_str_mv AT bezajobira hepaticsteatosisrelatestogastrointestinalmicrobiotachangesinobesegirlswithpolycysticovarysyndrome
AT danielnfrank hepaticsteatosisrelatestogastrointestinalmicrobiotachangesinobesegirlswithpolycysticovarysyndrome
AT lorijsilveira hepaticsteatosisrelatestogastrointestinalmicrobiotachangesinobesegirlswithpolycysticovarysyndrome
AT laurapyle hepaticsteatosisrelatestogastrointestinalmicrobiotachangesinobesegirlswithpolycysticovarysyndrome
AT meganmkelsey hepaticsteatosisrelatestogastrointestinalmicrobiotachangesinobesegirlswithpolycysticovarysyndrome
AT yeseniagarciareyes hepaticsteatosisrelatestogastrointestinalmicrobiotachangesinobesegirlswithpolycysticovarysyndrome
AT charleserobertson hepaticsteatosisrelatestogastrointestinalmicrobiotachangesinobesegirlswithpolycysticovarysyndrome
AT dianair hepaticsteatosisrelatestogastrointestinalmicrobiotachangesinobesegirlswithpolycysticovarysyndrome
AT kristenjnadeau hepaticsteatosisrelatestogastrointestinalmicrobiotachangesinobesegirlswithpolycysticovarysyndrome
AT melaniecreegreen hepaticsteatosisrelatestogastrointestinalmicrobiotachangesinobesegirlswithpolycysticovarysyndrome